Summary
In the present study equilibrium dialysis has been used to determine the degree of protein binding of the catecholamines adrenaline and noradrenalin and the adrenergic receptor blockers, prazosin and propranolol in diabetics.
The binding of the catecholamines in plasma from Type I and II diabetic patients was not significantly different from that of healthy subjects. The ratio of the bound and free catecholamine concentrations was correlated with the level of albumin (HSA).
Significantly reduced protein binding of prazosin was observed in Type I and II diabetic subjects compared to healthy volunteers. The binding of propranolol was significantly reduced in Type I patients.
The ratios between the bound and unbound concentrations of prazosin and propranolol were significantly correlated with the levels of a,-acid glycoprotein (AAG). The results suggest that non-enzymatic glycosylation of plasma proteins may increase the unbound fraction of the adrenergic blockers prazosin and propranolol.
Similar content being viewed by others
References
Ruiz-Cabello F, Erill S (1984) Abnormal serum protein bindingof acidic drugs in diabetes mellitus. Clin Pharmacol Ther 36: 691–695
Barry MG, Collins WCJ, Feely J (1986) Plasma protein binding of drugs in insulin dependent diabetes mellitus. Br J Pharmaco 189: 719p
Sager G (1990) Types ofβ-adrenergic binding sites on plasma proteins and blood cells. In: Belpaire F, Bogaert M, Tillement JP, Verbeeck R (eds) Plasma binding of drugs and its consequences. Academia Press, Ghent, pp 43–53
Rubin P, Blaschke T (1980) Prazosin protein binding in health and disease. Br J Clin Pharmacol 9: 177–182
Dale O, Nilsen OG (1984) Differences in the serum protein binding of prazosin in man and rat. Biochem Pharmacol 33: 1719–1724
Brunner F, Muller WE (1985) Prazosin binding to human α1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the „single drug binding site” of orosomucoid. J Pharm Pharmacol 37: 305–309
Sager G, Jæger R, Little C (1989) Binding of prazosin to α1-acid glycoprotein and albumin: effect of protein purity and concentrations. Pharmacol Toxicol 64: 365–368
Sager G, Bratlid H, Little C (1987) Binding of catecholamines to alpha-1 acid glycoprotein, albumin, and lipoproteins in human serum. Biochem Pharmacol 36: 3607–3612
Sager G, Slørdal L, Huseby NE, Florholmen J (1991)β-Adrenoceptor regulation in insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 51: 283–288
Hoeldtke RD, Boden G, Shuman CR, Owen OE (1982) Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med 96: 459–462
Berlin I, Grimaldi A, Bosquet F, Puech AJ (1986) Decreased, adrenergic sensitivity in insulin-dependent diabetic subjects. J Clin Endocrin Metab 63: 262–265
Berlin I, Grimaldi A, Landault C, Zoghbi F, Thervet F, Puech AJ, Legrand JC (1988) Lack of hypoglycemic symptoms and decreasedβ-adrenergic sensitivity in insulin-dependent patients. J Clin Endocrin Metab 66: 273–278
McMillan DE (1989) Increased levels of acute-phase serum proteins in diabetes. Metabolism 38: 1042–1046
Sager G, Hansteen V, Aakesson I, Jacobsen S (1981) Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction. Br J Clin Pharmacol 12: 613–620
Kremer JMH, Wilting J, Janssen LHM (1988) Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev 40: 1–47
Sager G, Trovik TS, Slørdal L, Jæger R, Prytz P, Brox J, Reiker⫗s O (1988) Catecholamine binding and concentrations in the acute phase plasma after surgery. Scand J Clin Lab Invest 48: 419–424
Ziegler MG, Lake CR, Kopin IJ (1976) Plasma noradrenaline increases with age. Nature 261: 333–335
Lake CR, Ziegler MG, Coleman MD, Kopin IJ (1977) Ageadjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. N Engl J Med 296: 208–209
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Trovik, T.S., Jaeger, R., Jorde, R. et al. Plasma protein binding of catecholamines, prazosin and propranolol in diabetes mellitus. Eur J Clin Pharmacol 43, 265–268 (1992). https://doi.org/10.1007/BF02333020
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02333020